4,900 results on '"Day, John"'
Search Results
52. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
53. Large deltas, small deltas: Toward a more rigorous understanding of coastal marine deltas
54. Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint Hypermobility
55. Author response: HiExM: high-throughput expansion microscopy enables scalable super-resolution imaging
56. HiExM: high-throughput expansion microscopy enables scalable super-resolution imaging
57. Advances and limitations for the treatment of spinal muscular atrophy
58. Telomere shortening is a hallmark of genetic cardiomyopathies
59. Maturation of the sella turcica and parasellar region: Surgical relevance for anterior skull base approaches in pediatric patients
60. Storied experiences of physical activity involvement, family membership and happiness
61. Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes
62. Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease
63. Conformational fingerprinting with Raman spectroscopy reveals protein structure as a translational biomarker of muscle pathology.
64. Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
65. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
66. Summary and Conclusions
67. Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry
68. Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy
69. Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)
70. 39 Mind the CURB! Improving adherence to guidelines for management of community-acquired pneumonia
71. Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)
72. Enabling large-scale production of algal oil in continuous output mode
73. Removal of metals from aqueous solutions using dried Cladophora parriaudii of varying biochemical composition
74. Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen
75. Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease
76. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
77. Subject-Predicate Inductive Probabilification-Judgement-Formulas
78. The Philosophical Problem of Inductive Probability
79. Inductive Probabilification by Elimination
80. Other Alleged Determinants of Inductive Probability
81. Inductive Reasoning and Inductive Logic
82. Functional Inductive Probabilification-Judgement-Formulas
83. Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
84. Large Infrequently Operated River Diversions for Mississippi Delta Restoration
85. Summary and Conclusions
86. The Costs and Sustainability of Ongoing Efforts to Restore and Protect Louisiana’s Coast
87. Introduction – Changing Conditions in the Mississippi Delta from 1700 to 2100 and Beyond: Avoiding Folly
88. Energy and Climate – Global Trends and Their Implications for Delta Restoration
89. A Brief History of Delta Formation and Deterioration
90. Optimum Use of Fresh Water to Restore Baldcypress – Water Tupelo Swamps and Freshwater Marshes and Protect Against Salt Water Intrusion: A Case Study of the Lake Pontchartrain Basin
91. The layers of an onion
92. Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ Study.
93. A review of emerging organic contaminants (EOCs), antibiotic resistant bacteria (ARB), and antibiotic resistance genes (ARGs) in the environment: Increasing removal with wetlands and reducing environmental impacts
94. Surgical Treatment of Symptomatic Small Medial Petrous Meningiomas Causing Trigeminal Neuralgia
95. Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation
96. Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial
97. Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease
98. Restoration of Tidal Marshes
99. Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy
100. Generation of two induced pluripotent stem cell lines from Duchenne muscular dystrophy patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.